The cAMP response element modulator (CREM) regulates TH2 mediated

Oncotarget

Volumn 6, Issue 36, 2015, Pages 38538-38551

  Verjans, Eva ^a,b   Ohl, Kim ^a   Reiss, Lucy K ^b   van Wijk, Femke ^c   Toncheva, Antonaneta A ^d   Wiener, Anastasia ^a   Yu, Yin ^a   Rieg, Annette D ^a,b   Gaertner, Vincent D ^d   Roth, Johannes ^e   Knol, Edward ^c   Kabesch, Michael ^d,f   Wagner, Norbert ^a   Uhlig, Stefan ^b   Martin, Christian ^b   Tenbrock, Klaus ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f German Center of Lung Research (DZL)   (Germany)

Author keywords

Allergic disease; Asthmatic response; Immune response; Immunity; Immunology Section; T cell dysregulation; TH2; Transcription factor

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR ALPHA; INTERLEUKIN 2; STAT5 PROTEIN; UNCLASSIFIED DRUG; CREM PROTEIN, HUMAN; CYTOKINE;

ADULT; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CREM GENE; DISEASE EXACERBATION; DOWN REGULATION; GENE; GENE DELETION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IL 13 GENE; IL 4 GENE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; TH2 CELL; ADOLESCENT; ANIMAL; ASTHMA; BIOSYNTHESIS; FEMALE; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATION; TRANSGENIC MOUSE; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; ASTHMA; CHILD; CYCLIC AMP RESPONSE ELEMENT MODULATOR; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; HYPERSENSITIVITY; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; TH2 CELLS; YOUNG ADULT;

EID: 84948783311     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6041     Document Type: Article

References (53)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet, 1998. 351: 1225-32.
2. Lai, C.K., R. Beasley, J. Crane, S. Foliaki, J. Shah, S. Weiland, A. International Study of, G. Allergies in Childhood Phase Three Study, Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax, 2009. 64: 476-83.
3. Buc, M., M. Dzurilla, M. Vrlik, M. Bucova, Immunopathogenesis of bronchial asthma. Arch Immunol Ther Exp (Warsz), 2009. 57: 331-44.
4. Mathias, C.B., L.A. Guernsey, D. Zammit, C. Brammer, C.A. Wu, R.S. Thrall, H.L. Aguila, Pro-inflammatory role of natural killer cells in the development of allergic airway disease. Clin Exp Allergy, 2014. 44: 589-601.
5. Scanlon, S.T., A.N. McKenzie, Type 2 innate lymphoid cells: new players in asthma and allergy. Curr Opin Immunol, 2012. 24: 707-12.
6. Suarez, C.J., N.J. Parker, P.W. Finn, Innate immune mechanism in allergic asthma. Curr Allergy Asthma Rep, 2008. 8: 451-9.
7. Minnicozzi, M., R.T. Sawyer, M.J. Fenton, Innate immunity in allergic disease. Immunol Rev, 2011. 242: 106-27.
8. Holgate, S.T., Innate and adaptive immune responses in asthma. Nat Med, 2012. 18: 673-83.
9. Renauld, J.C., New insights into the role of cytokines in asthma. J Clin Pathol, 2001. 54: 577-89.
10. Finiasz, M., C. Otero, L. Bezrodnik, S. Fink, The role of cytokines in atopic asthma. Curr Med Chem, 2011. 18: 1476-87.
11. Zheng, W., R.A. Flavell, The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell, 1997. 89: p. 587-96.
12. Ho, I.C., L.H. Glimcher, Transcription: tantalizing times for T cells. Cell, 2002. 109 Suppl: S109-20.
13. Zeng, W.P., 'All things considered': transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation. Immunology, 2013. 140: 31-8.
14. Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H.A. Young, J. Hu-Li, J. Zhu, W.E. Paul, Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A, 2004. 101: 3880-5.
15. Zhu, J., J. Cote-Sierra, L. Guo, W.E. Paul, Stat5 activation plays a critical role in Th2 differentiation. Immunity, 2003. 19: 739-48.
16. Liao, W., D.E. Schones, J. Oh, Y. Cui, K. Cui, T.Y. Roh, K. Zhao, W.J. Leonard, Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor alpha-chain expression. Nat Immunol, 2008. 9: p. 1288-96.
17. Tripathi, S.K., R. Lahesmaa, Transcriptional and epigenetic regulation of T-helper lineage specification. Immunol Rev, 2014. 261: 62-83.
18. Kapitein, B., M.O. Hoekstra, E.H. Nijhuis, D.J. Hijnen, H.G. Arets, J.L. Kimpen, E.F. Knol, Gene expression in CD4+ T-cells reflects heterogeneity in infant wheezing phenotypes. Eur Respir J, 2008. 32: 1203-12.
19. Rauen, T., C.M. Hedrich, K. Tenbrock, G.C. Tsokos, cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med, 2013. 19: 262-9.
20. Kyttaris, V.C., Y. Wang, Y.T. Juang, A. Weinstein, G.C. Tsokos, CAMP response element modulator a expression in patients with systemic lupus erythematosus. Lupus, 2006. 15: 840-4.
21. Hedrich, C.M., T. Rauen, G.C. Tsokos, cAMP-responsive element modulator (CREM)alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus. J Biol Chem, 2011. 286: 43429-36.
22. Lee, H.J., N. Koyano-Nakagawa, Y. Naito, J. Nishida, N. Arai, K. Arai, T. Yokota, cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J Immunol, 1993. 151: 6135-42.
23. Klein-Hessling, S., T. Bopp, M.K. Jha, A. Schmidt, S. Miyatake, E. Schmitt, E. Serfling, Cyclic AMP-induced chromatin changes support the NFATc-mediated recruitment of GATA-3 to the interleukin 5 promoter. J Biol Chem, 2008. 283: 31030-7.
24. Yano, S., P. Ghosh, H. Kusaba, M. Buchholz, D.L. Longo, Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population. J Immunol, 2003. 171: 2510-6.
25. De Cesare, D., P. Sassone-Corsi, Transcriptional regulation by cyclic AMP-responsive factors. Prog Nucleic Acid Res Mol Biol, 2000. 64: 343-69.
26. Sassone-Corsi, P., Coupling gene expression to cAMP signalling: role of CREB and CREM. Int J Biochem Cell Biol, 1998. 30: 27-38.
27. Gilchrist, M., W.R. Henderson, Jr., A.E. Clark, R.M. Simmons, X. Ye, K.D. Smith, A. Aderem, Activating transcription factor 3 is a negative regulator of allergic pulmonary inflammation. J Exp Med, 2008. 205: 2349-57.
28. Seumois, G., L. Chavez, A. Gerasimova, M. Lienhard, N. Omran, L. Kalinke, M. Vedanayagam, A.P. Ganesan, A. Chawla, R. Djukanovic, K.M. Ansel, B. Peters, A. Rao, et al., Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility. Nat Immunol, 2014. 15: 777-88.
29. Tenbrock, K., Y.T. Juang, M.F. Gourley, M.P. Nambiar, G.C. Tsokos, Antisense cyclic adenosine 5'-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol, 2002. 169: 4147-52.
30. Lippe, R., K. Ohl, G. Varga, T. Rauen, J.C. Crispin, Y.T. Juang, S. Kuerten, F. Tacke, M. Wolf, K. Roebrock, T. Vogl, E. Verjans, N. Honke, et al., CREMalpha overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity. J Mol Cell Biol, 2012. 4: 121-3.
31. Kaplan, M.H., U. Schindler, S.T. Smiley, M.J. Grusby, Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity, 1996. 4: 313-9.
32. Zhang, F., D.Z. Wang, M. Boothby, L. Penix, R.A. Flavell, T.M. Aune, Regulation of the activity of IFN-gamma promoter elements during Th cell differentiation. J Immunol, 1998. 161: 6105-12.
33. Fernandez, D., E. Bonilla, P. Phillips, A. Perl, Signaling abnormalities in systemic lupus erythematosus as potential drug targets. Endocr Metab Immune Disord Drug Targets, 2006. 6: 305-11.
34. Tenbrock, K., Y.T. Juang, M. Tolnay, G.C. Tsokos, The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol, 2003. 170: 2971-6.
35. Juang, Y.T., Y. Wang, E.E. Solomou, Y. Li, C. Mawrin, K. Tenbrock, V.C. Kyttaris, G.C. Tsokos, Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest, 2005. 115: 996-1005.
36. Ichinose, K., Y.T. Juang, J.C. Crispin, K. Kis-Toth, G.C. Tsokos, Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Arthritis Rheum, 2011. 63: 523-9.
37. Humrich, J.Y., C. von Spee-Mayer, E. Siegert, T. Alexander, F. Hiepe, A. Radbruch, G.R. Burmester, G. Riemekasten, Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE. Ann Rheum Dis, 2015. 74: 791-2.
38. Ohl, K., A. Wiener, A. Schippers, N. Wagner, K. Tenbrock, IL-2 treatment reverses effects of CREMalpha-overexpressing T cells in autoimmune-prone mice. Clin Exp Immunol, 2015.
39. Ohl, K., K. Tenbrock, Regulatory T cells in systemic lupus erythematosus. Eur J Immunol, 2015. 45: 344-55.
40. Loppow, D., E. Huland, H. Heinzer, L. Gronke, H. Magnussen, O. Holz, R.A. Jorres, Interleukin-2 inhalation therapy temporarily induces asthma-like airway inflammation. Eur J Med Res, 2007. 12: 556-62.
41. Busse, W.W., E. Israel, H.S. Nelson, J.W. Baker, B.L. Charous, D.Y. Young, V. Vexler, R.S. Shames, G. Daclizumab Asthma Study, Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am J Respir Crit Care Med, 2008. 178: 1002-8.
42. Tenbrock, K., Y.T. Juang, N. Leukert, J. Roth, G.C. Tsokos, The transcriptional repressor cAMP response element modulator alpha interacts with histone deacetylase 1 to repress promoter activity. J Immunol, 2006. 177: 6159-64.
43. Ahlmann, M., G. Varga, K. Sturm, R. Lippe, K. Benedyk, D. Viemann, T. Scholzen, J. Ehrchen, F.U. Muller, M. Seidl, M. Matus, G.C. Tsokos, J. Roth, et al., The cyclic AMP response element modulator [alpha] suppresses CD86 expression and APC function. J Immunol, 2009. 182: 4167-74.
44. Rauen, T., C.M. Hedrich, Y.T. Juang, K. Tenbrock, G.C. Tsokos, cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J Biol Chem, 2011. 286: 43437-46.
45. Hellings, P.W., A. Kasran, Z. Liu, P. Vandekerckhove, A. Wuyts, L. Overbergh, C. Mathieu, J.L. Ceuppens, Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol, 2003. 28: 42-50.
46. Doe, C., M. Bafadhel, S. Siddiqui, D. Desai, V. Mistry, P. Rugman, M. McCormick, J. Woods, R. May, M.A. Sleeman, I.K. Anderson, C.E. Brightling, Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest, 2010. 138: 1140-7.
47. Wilson, R.H., G.S. Whitehead, H. Nakano, M.E. Free, J.K. Kolls, D.N. Cook, Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med, 2009. 180: 720-30.
48. Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, B. Schnyder, Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med, 2006. 203: 2715-25.
49. Verjans, E., K. Ohl, Y. Yu, R. Lippe, A. Schippers, A. Wiener, J. Roth, N. Wagner, S. Uhlig, K. Tenbrock, C. Martin, Overexpression of CREMalpha in T cells aggravates lipopolysaccharide-induced acute lung injury. J Immunol, 2013. 191: 1316-23.
50. Sekigawa, I., T. Yoshiike, N. Iida, H. Hashimoto, H. Ogawa, Allergic disorders in systemic lupus erythematosus: prevalence and family history. Lupus, 2002. 11: 426-9.
51. Nicklin, A., R.W. Byard, Lethal manifestations of systemic lupus erythematosus in a forensic context. J Forensic Sci, 2011. 56: 423-8.
52. Livak, K.J., T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 2001. 25: 402-8.
53. Martin, C., H.D. Held, S. Uhlig, Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Naunyn Schmiedebergs Arch Pharmacol, 2000. 362: 128-36.